Stress and self-injurious behavior; hormonal and serotonergic parameters in mentally retarded subjects. 1999

W M Verhoeven, and S Tuinier, and Y W van den Berg, and A M Coppus, and D Fekkes, and L Pepplinkhuizen, and J H Thijssen
Vincent van Gogh Institute for Psychiatry, Venray, The Netherlands.

Self-injurious behavior (SIB) and stereotyped behavior (SB) are major challenges for professionals in the field of mental retardation. From animal experiments it has become obvious that these behavioral disturbances are not purposeless but may emerge secondary to restrictive environment and may serve de-arousing objectives. In mentally retarded subjects, several hypotheses have been formulated concerning the pathogenesis of SIB, particularly about the involvement of serotonin and beta-endorphin, which are supported by beneficial treatment effects of the opiate antagonist naltrexone and serotonin modulating compounds, respectively. The present study was designed to investigate basal levels of stress-hormonal and serotonergic parameters as well as plasma levels of amino-acids and the beta-carboline norharman in a group of 64 mentally retarded subjects with SB and/or SIB. Allocation to three different groups comprising 17 retarded controls, 26 subjects with mainly SIB and 21 subjects with mainly SB, was originally performed using the scores on the factors Irritability, Stereotypic Behaviour and Hyperactivity of the Aberrant Behavioral Checklist. Because of the overlapping nature of the behavioral parameters, subjects were subsequently divided into three maximally contrasting groups, viz. predominantly SIB, predominantly SB and retarded controls, each comprising 11 subjects. With respect to beta-endorphin, no differences were found either between both the original and maximally contrasting groups or in comparison to nonretarded controls. As compared to retarded controls, a tendency to lower values for total cortisol and cortisol binding globulin appeared to be present in the SIB group, whereas in the SB group a tendency toward higher levels of the major serotonin metabolite 5-HIAA was found. In the contrasting SB group, a trend toward decreased total cortisol level was observed as compared to the retarded control group. In addition, significantly lower values for norharman and tryptophan were demonstrated in the total group of mentally retarded subjects as compared to non-retarded controls. The results of the present study, yielding co-existent disturbances in stress-hormonal and monoaminergic mechanisms as well as in the metabolism of norharman, are in line with the hypothesis that mentally retarded subjects are at risk for the development of stress-related behavioral disorders such as SIB and SB.

UI MeSH Term Description Entries
D008297 Male Males
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D002243 Carbolines A group of pyrido-indole compounds. Included are any points of fusion of pyridine with the five-membered ring of indole and any derivatives of these compounds. These are similar to CARBAZOLES which are benzo-indoles. Carboline,Pyrido(4,3-b)Indole,Beta-Carbolines,Pyrido(4,3-b)Indoles,Beta Carbolines
D005260 Female Females
D006247 Harmine Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is one of the active ingredients of hallucinogenic drinks made in the western Amazon region from related plants. It has no therapeutic use, but (as banisterine) was hailed as a cure for postencephalitic PARKINSON DISEASE in the 1920's. 9H-Pyrido(3,4-b)indole, 7-methoxy-1-methyl-,Banisterine,Leucoharmine,Telepathine,Yageine
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino

Related Publications

W M Verhoeven, and S Tuinier, and Y W van den Berg, and A M Coppus, and D Fekkes, and L Pepplinkhuizen, and J H Thijssen
April 1990, Biological psychiatry,
W M Verhoeven, and S Tuinier, and Y W van den Berg, and A M Coppus, and D Fekkes, and L Pepplinkhuizen, and J H Thijssen
May 1987, Journal of the American Academy of Child and Adolescent Psychiatry,
W M Verhoeven, and S Tuinier, and Y W van den Berg, and A M Coppus, and D Fekkes, and L Pepplinkhuizen, and J H Thijssen
November 1999, Der Nervenarzt,
W M Verhoeven, and S Tuinier, and Y W van den Berg, and A M Coppus, and D Fekkes, and L Pepplinkhuizen, and J H Thijssen
August 1990, Journal of clinical psychopharmacology,
W M Verhoeven, and S Tuinier, and Y W van den Berg, and A M Coppus, and D Fekkes, and L Pepplinkhuizen, and J H Thijssen
September 1985, Journal of autism and developmental disorders,
W M Verhoeven, and S Tuinier, and Y W van den Berg, and A M Coppus, and D Fekkes, and L Pepplinkhuizen, and J H Thijssen
January 1984, Applied research in mental retardation,
W M Verhoeven, and S Tuinier, and Y W van den Berg, and A M Coppus, and D Fekkes, and L Pepplinkhuizen, and J H Thijssen
January 1989, Psychopharmacology bulletin,
W M Verhoeven, and S Tuinier, and Y W van den Berg, and A M Coppus, and D Fekkes, and L Pepplinkhuizen, and J H Thijssen
January 1989, Psychopharmacology bulletin,
W M Verhoeven, and S Tuinier, and Y W van den Berg, and A M Coppus, and D Fekkes, and L Pepplinkhuizen, and J H Thijssen
May 1995, Psychiatric services (Washington, D.C.),
W M Verhoeven, and S Tuinier, and Y W van den Berg, and A M Coppus, and D Fekkes, and L Pepplinkhuizen, and J H Thijssen
August 1986, The New England journal of medicine,
Copied contents to your clipboard!